Which document details the FDA’s expectations for electronic submission of data?

The document that outlines the FDA's expectations for electronic submission of data is the Study Data Standards document. This document provides guidance on the structure, content, and format of data submissions to ensure that they meet regulatory requirements and facilitate the review process. By adhering to these standards, sponsors can help ensure that their submissions are complete and meet the FDA's expectations.

This guidance allows for better consistency and clarity in the data that is submitted, which ultimately aids the FDA in their evaluation and decision-making processes regarding new therapies and treatments. Thus, understanding and utilizing the Study Data Standards is crucial for anyone engaged in the preparation of clinical trial data submissions to the FDA.